SCHEMBL262182

SCHEMBL262182

NC(=O)C1C[CH]CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2402382 1.00
SCHEMBL2541559 0.88
SCHEMBL1385858 0.86
SCHEMBL2537996 0.86 KMT2A (0.41)
SCHEMBL2534890 0.84 CES2 (0.41)
Hydrochloric Acid SCHEMBL27755494 0.84 SMN1; SMN2 (0.40)
SCHEMBL1435138 0.80
SCHEMBL16587928 0.80
SCHEMBL15929785 0.80
SCHEMBL4612793 0.80

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 566 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7939548-B2 Aminopyridines, e.g.,N-{[6-(aminomethyl)(2-pyridyl)]methyl}(2-{[2-(3-fluorophenyl)ethyl]amino}-5-(3-pyridyl)(3-pyridyl))carboxamide; smooth muscle myosin or non-muscle myosin modulator; hypotensive agent; asthma, COPD, bronchoconstrictive disease, glaucoma, pre-menstrual cramps, erectile dysfunction CYTOKINETICS, INC. (US) 2011-05-10 US claimed
US-7932270-B2 Certain chemical entities, compositions, and methods CYTOKINETICS, INC. (US) 2011-04-26 US claimed
US-20090069321-A1 CYANOMETHYL SUBSTITUTED N-ACYL TRYPTAMINES BAYER SCHERING PHARMA AG (DE) 2009-03-12 US claimed
WO-2009016253-A2 CYANOMETHYL SUBSTITUTED N-ACYL TRYPTAMINES BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2009-02-05 WO claimed
EP-2020404-A1 Cyanomethyl substituted N-Acyl Tryptamines Bayer Schering Pharma Aktiengesellschaft (DE) 2009-02-04 EP claimed
US-20090012126-A1 Certain chemical entities, compositions, and methods CYTOKINETICS, INC. 2009-01-08 US claimed
US-20080139575-A1 Certain chemical entities, compositions, and methods CYTOKINETICS, INC. 2008-06-12 US claimed
US-20080132545-A1 Certain chemical entities, compositions, and methods CYTOKINETICS, INC. 2008-06-05 US claimed
WO-2008016643-A2 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS CYTOKINETICS, INCORPORATED (US) 2008-02-07 WO claimed
CN-115335464-B Hydrophobic coating composition 迈图高新材料公司 2024-03-26 CN disclosed
EP-4305116-A1 SILICON-BASED COMPOSITIONS AND APPLICATIONS THEREOF Momentive Performance Materials Inc. (US) 2024-01-17 EP disclosed
US-20240010786-A9 POLYOL COMPOSITIONS PRESIDIUM INNOVATIONS, LLC 2024-01-11 US disclosed
CN-113423767-B Curable silicone-based composition and use thereof 迈图高新材料公司 2024-01-09 CN disclosed
CN-117280004-A Silicon-based composition and use thereof 迈图高新材料公司 2023-12-22 CN disclosed
US-20060093826-A1 Compositions useful as coatings, their preparation, and articles made therefrom GENERAL ELECTRIC COMPANY (US) 2006-05-04 US disclosed
EP-1642898-A1 HETEROARYLOXY NITROGENOUS SATURATED HETEROCYCLIC DERIVATIVE BANYU PHARMACEUTICAL CO., LTD. (JP) 2006-04-05 EP disclosed
US-20060030683-A1 Polyethersulfone compositions GENERAL ELECTRIC COMPANY 2006-02-09 US disclosed
US-20050256290-A1 Monomers and polymers comprising conjugated groups and methods for making thereof GENERAL ELECTRIC COMPANY 2005-11-17 US disclosed
WO-2005073271-A1 COMPOSITIONS USEFUL AS COATINGS, THEIR PREPARATION, AND ARTICLES MADE THEREFROM GENERAL ELECTRIC COMPANY (US) 2005-08-11 WO disclosed
US-20050159542-A1 Compositions useful as coatings, their preparation, and articles made therefrom GENERAL ELECTRIC COMPANY 2005-07-21 US disclosed